David Furman, PhD

“Human beings have a biology that can be targeted and treated. Focusing on functional and intrinsic changes within the body yields insights into the risks for developing age-related diseases before the person sees decline. It’s an incredible diagnostic tool that’s ushering in the age of better aging.” 

A member of the Amway Scientific Advisory Board, Dr. David Furman is a sought-after researcher, innovator, and thought leader in the aging of the immune system. He dedicates his work to understanding how the inflammatory response within the immunome – the totality of genes, metabolites, and cells that contribute to an immune response in the body – affects aging and the development of chronic, non-communicable diseases, to identify early predictors of decline and, ultimately, proactively support healthspan – the number of years a person is able to enjoy an active, independent life.  

“Historically, medicine has pursued lifespan extension but I believe this is the wrong approach. We have pushed lifespan out 50 years over the past 200 years but the last decades of life are often lived sick – the average person 65 years or older takes 14 medications. Healthspan is about living longer and better by maintaining the body’s functional ability and intrinsic capacity.” 

The first biological markers of aging on a cellular and molecular level, often before visible changes occur. Biological age can be measured in early adulthood, which empowers people to make lifestyle changes to improve their healthspan from a younger age.  

Dr. Furman is Director of the Stanford 1,000 Immunomes Project. He also serves as Chief of Artificial Intelligence Platform and Associate Professor in Applied Artificial Intelligence in Systems and Computational Immunology of Aging at Buck Institute for Research on Aging, the world’s first research institution singularly focused on the biology of aging. 

Novel technologies developed by the Furman Lab at Buck include an AI platform that keeps scientists from drowning in a sea of data. “What would take hundreds of people dozens of years to analyze can now be done efficiently. Twenty years ago, scientists studied the immunome by measuring 40 proteins and a handful of genes. Today we can detect more than 10,000 proteins and whole genome sequencing of 20,000 or more genes to quickly identify which factors contribute most to aging and which interventions best target those factors.” 

An academic entrepreneur, Dr. Furman is also Founder of the American Inflammaging Institute, which exists to make the complex biology of aging accessible to everybody; Co-Founder and Scientific Advisory Board Chairman of Edifice Health; and Founder and Chief Science Officer of Cosmica Biosciences. 

An inventor with more than 25 patents in his name, Dr. Furman has published nearly 50 scientific articles in top peer-reviewed journals like Cell, Nature Medicine, Proceedings of the National Academy of Sciences (PNAS), and The Lancet. He also serves on the Reverse Aging Science Board of Parfums Christian Dior. 

Dr. Furman holds a Bachelor of Science in Biology from the University of Concepción in Chile and a Ph.D. in Immunology from the School of Medicine, University of Buenos Aires in Argentina. He also completed post-doctoral training in Systems Immunology/Bioinformatics at Stanford University in the United States.